Pharmaphil Overview

  • Founded
  • 1965
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 100
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 2

Pharmaphil General Information

Description

Manufacturer of two-piece hardcapsules in North America. The company's products are used by some of the largest Pharmaceutical and Dietary Supplement manufacturers in North America. The company's empty capsule products are used with powders, pellets, beads, tablets, pastes and liquids.

Contact Information

Formerly Known As
RP Schere
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Delivery
Acquirer
Primary Office
  • 3190 Devon Drive
  • Windsor, Ontario N8X 4L2
  • Canada
+1 (519) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmaphil Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pharmaphil‘s full profile, request access.

Request a free trial

Pharmaphil Executive Team (5)

Name Title Board Seat Contact Info
Joseph Clark III President
Dave Kirby Chief Financial Officer
John Mikhail Vice President
Vancho Cirovski Vice President
Jack Cashman Chairman
To view Pharmaphil’s complete executive team members history, request access »

Pharmaphil Board Members (1)

Name Representing Role Since
0000 0000000 Pharmaphil Chairman 000 0000
To view Pharmaphil’s complete board members history, request access »

Pharmaphil Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial